Claude Allary
Director/Board Member chez ARCH BIOPARTNERS INC.
Fortune : 341 550 $ au 31/03/2024
Provenance du réseau au premier degré de Claude Allary
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Other | 17 | |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France.
10
| Non-Profit Organization | Biotechnology | 10 |
Public Company | Pharmaceuticals: Major | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Claude Allary via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
DANONE | Food: Meat/Fish/Dairy | Public Communications Contact Chief Tech/Sci/R&D Officer | |
TRANSGENE | Biotechnology | Director/Board Member | |
HELIX BIOPHARMA CORP. | Pharmaceuticals: Major | Director/Board Member | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Comptroller/Controller/Auditor | |
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
BIODESIX, INC. | Medical/Nursing Services | Director/Board Member | |
Pierre Fabre SA
Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MERRIMACK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
McGill University | College/University | Undergraduate Degree Undergraduate Degree | |
Hofstra University | College/University | Undergraduate Degree | |
European Business School Group
European Business School Group Other Consumer ServicesConsumer Services The European Business School Group functions as a college or university. The company is based in Paris, France. | Other Consumer Services | Masters Business Admin | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Undergraduate Degree Graduate Degree | |
International Institute of New England, Inc.
International Institute of New England, Inc. Services to the Health IndustryHealth Services International Institute of New England, Inc. operates as a non-profit organization serving immigrants, refugees, asylees, and other vulnerable populations. Its services include refugee resettlement, case management, health services navigation, employment, education and literacy and citizenship programming. The company was founded in 1910 and is headquartered in Boston, MA. | Services to the Health Industry | Director/Board Member | |
French-American Chamber of Commerce
French-American Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The French-American Chamber of Commerce (FACC) is a non-profit, member-driven organization founded in 1985. The non-profit company is based in Atlanta, GA. The FACC is part of a network of 18 French-American chambers representing over 5,000 companies nationwide in all major industries. The company is also a proud member of CCI International, an international network of 124 French chambers of commerce in 95 countries, representing over 37,000 members worldwide. The FACC's mission is to promote, support, and enhance business opportunities among the French-American business community throughout the Southeast of the United States. The company provides opportunities for members to network, connect, collaborate, and learn from one another through events and programs. The FACC is the main professional forum and business resource for French companies and their leaders doing business in and with the Southeast of the United States, and for companies in the Southeast of the United States doing business in and with France. The company also provides a range of trade services to their local members and to French businesses and entrepreneurs seeking to develop their business in the Southeast of the United States. | Miscellaneous Commercial Services | President | |
École Supérieure Libre des Sciences Commerciales Appliquées | College/University | Masters Business Admin | |
bioMérieux, Inc.
bioMérieux, Inc. Medical SpecialtiesHealth Technology bioMérieux, Inc. develops in-vitro diagnostics solutions. It offers microbiological testing solutions for medical and industrial applications. The company was founded on December 31, 1986 and is headquartered in Durham, NC. | Medical Specialties | Corporate Officer/Principal | |
TXCELL | Pharmaceuticals: Major | Director/Board Member | |
Association Française contre les Myopathies
Association Française contre les Myopathies Miscellaneous Commercial ServicesCommercial Services The Association Française contre les Myopathies is a foundation dedicated to the research, treatment, awareness of neuromuscular diseases, aiming to help improve the patients' expectancy and quality of life. They offer services such as diagnostic tests, home therapy support, and enablement programs for education and daily living. The firm was founded in 1958, and is based in Evry. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
VISIONEERING TECHNOLOGIES, INC. | Electronic Components | Director/Board Member | |
Cargill France SAS
Cargill France SAS Agricultural Commodities/MillingProcess Industries Cargill France SAS engages in trading corn and soy flours. It also provides meat and chicken processing, chocolate and food ingredients. The company was founded in 1964 and is headquartered in Saint-Germain-en-Laye, France. | Agricultural Commodities/Milling | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
AgroParisTech | College/University | Doctorate Degree | |
Sorbonne Université | College/University | Corporate Officer/Principal | |
Hera Diagnostics SAS | Corporate Officer/Principal | ||
HepatoChem, Inc.
HepatoChem, Inc. Pharmaceuticals: MajorHealth Technology HepatoChem, Inc. provides pharmaceutical and biotech services. Its services include metabolite synthesis, chemical diversity, chemistry kits, metabolite structure elucidation, metabolic stability study and analytical services. The company was founded in 2008 by Marc Bazin and John T. Groves and is headquartered in Beverly, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
SAFE ORTHOPAEDICS SA | Medical Specialties | Director/Board Member | |
DIMENSION THERAPEUTICS INC | Biotechnology | Director of Finance/CFO | |
DRONE VOLT | Aerospace & Defense | Director/Board Member Founder | |
REPLIMUNE GROUP, INC. | Biotechnology | Director of Finance/CFO | |
Dynacure SA
Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Director/Board Member | |
Yposkesi
Yposkesi BiotechnologyHealth Technology Part of SK, Inc., Yposkesi is a French-based CDMO that offers bioprocess development and CGMP manufacturing services for AAV and lentiviral vector production. The private company is based in Corbeil-Essonnes, France. The French company provides support for gene therapy and aims to provide the best and most complete viral vector solutions. Yposkesi provides flexibility to develop the best process for cell and gene therapy production and process for viral vector. The company was founded in 2015, and Alain Lamproye has been the CEO of the company since 2017. Yposkesi was acquired by SK Pharmteco, Inc. on March 31, 2021. | Biotechnology | Chairman | |
Biophytis, Inc.
Biophytis, Inc. Pharmaceuticals: MajorHealth Technology Part of Biophytis SA, Biophytis, Inc. operates as a clinical-stage biotechnology company which develops therapeutics for aging and improving functional outcomes. The private company is based in Newark, DE. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
Coretec Industry Group SAS
Coretec Industry Group SAS MiscellaneousMiscellaneous Coretec Industry Group SAS operates as a holding French company. The private company is based in Paris, France. | Miscellaneous | Director/Board Member | |
French Tech Hub
French Tech Hub Information Technology ServicesTechnology Services French Tech Hub provides technical expert services for companies. | Information Technology Services | Corporate Officer/Principal | |
Flamingo Therapeutics BV
Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | Miscellaneous Commercial Services | Director/Board Member | |
Université Paris-Saclay | College/University | Doctorate Degree | |
Atamyo Therapeutics SAS
Atamyo Therapeutics SAS BiotechnologyHealth Technology Atamyo Therapeutics SAS is a clinical-stage biopharmaceutical company based in France. Atamyo leverages unique expertise in AAV-based gene therapy and muscular dystrophies from the Progressive Muscular Dystrophies Laboratory at Genethon, a spin-off of gene therapy pioneer Genethon. Atamyo's most advanced programs address different forms of limb-girdle muscular dystrophies (LGMD), with two clinical-stage programs targeting respectively LGMD-R9 and LGMD-R5. The name of the French company is derived from two words\: Celtic Atao which means "always" or "forever" and Myo which is the Greek root for muscle. Atamyo conveys the spirit of its commitment to improve the life of patients affected by neuromuscular diseases with life-long efficient treatments. Atamyo brings to patients with musculoskeletal diseases a new generation of gene therapies with enhanced safety and efficacy. The private company was founded in 2020 by Stéphane Degove and Isabelle Richard. Stéphane Degove has been the CEO since 2020. | Biotechnology | Chairman Director/Board Member | |
Axelia Partners LLC
Axelia Partners LLC Miscellaneous Commercial ServicesCommercial Services Part of Zedra Fund Managers (Guernsey) Ltd., Axelia Partners LLC provides administration, accounting, tax, paralegal and payroll services. The private company is based in Cambridge, MA. The company was founded in 1989 by Marie-Yvonne Landel-Meunier. Axelia Partners was acquired by Zedra Fund Managers (Guernsey) Ltd. on November 14, 2022. | Miscellaneous Commercial Services | Founder | |
Gerondif | Director/Board Member | ||
Society for Research on the Cerebellum & Ataxias | President | ||
Women Initiative Foundation | Corporate Officer/Principal | ||
Successful Life SAS | President | ||
CELLNOVO | Medical Specialties | Director/Board Member | |
Good Start Genetics, Inc.
Good Start Genetics, Inc. Medical/Nursing ServicesHealth Services Good Start Genetics, Inc. operates as a molecular diagnostics firm. It offers pre-pregnancy diagnostic test services to screen a panel of genetic disorders. The firm also provides clinical laboratory and genetic counseling support services. The company was founded by Eric Boutin, Paris Wallace, and Gregory J. Porreca in December 2007 and is headquartered in Cambridge, MA. | Medical/Nursing Services | Director of Finance/CFO |
Statistiques
Internationale
France | 29 |
Etats-Unis | 17 |
Canada | 3 |
Belgique | 3 |
Suède | 2 |
Sectorielle
Health Technology | 21 |
Consumer Services | 11 |
Health Services | 5 |
Commercial Services | 5 |
Electronic Technology | 3 |
Opérationnelle
Director/Board Member | 55 |
Corporate Officer/Principal | 43 |
Chairman | 24 |
Independent Dir/Board Member | 20 |
Director of Finance/CFO | 19 |
Relations les plus connectées
Insiders | |
---|---|
Patrick Volkert Vink | 30 |
Jean Franchi | 17 |
Adrian Haigh | 15 |
Marie-Yvonne Landel-Meunier | 13 |
Philippe Rousseau | 12 |
Andrew Bishop | 10 |
Frédéric Revah | 9 |
Evelyne Nguyen | 9 |
Stanislas Veillet | 7 |
Nadine Coulm | 7 |
Alexandre Lemoalle | 6 |
Waly Dioh | 6 |
Jean Mariani | 6 |
Nicolas Fellmann | 6 |
Richard Muruve | 6 |
- Bourse
- Insiders
- Claude Allary
- Connexions Sociétés